Skip to main content

Table 5 Antibiotic Susceptibility Patterns of Uropathogens in the MIST Study

From: Urinary tract infections in pregnancy in a rural population of Bangladesh: population-based prevalence, risk factors, etiology, and antibiotic resistance

 Escherichia coliKlebsiella speciesStaphylococcus aureusStaph species (non-aureus)Group B StrepBeta-hemolytic Streptococcus
Cefixime82/119a (68.9%)34/36 (94.4%)0/74/28 (14.3%)4/7 (57.1%)11/11 (100.0%)
Nitrofurantoin117/118 (99.2%)26/35 (74.3%)7/7 (100.0%)28/28 (100.0%)7/7 (100.0%)11/11 (100.0%)
Ampicillin40/119 (33.6%)3/36 (8.3%)3/7 (42.9%)16/28 (57.1%)7/7 (100.0%)10/11 (90.9%)
Azithromycin34/120 (28.3%)3/36 (8.3%)3/7 (42.9%)22/28 (78.6%)2/7 (28.6%)6/11 (54.5%)
Cotrimoxazole74/118 (62.7%)35/36 (97.2%)6/7 (85.7%)23.28 (82.1%)7/7 (100.0%)11/11 (100.0%)
Gentamicin97/117 (82.9%)33/36 (91.7%)6/7 (85.7%)24/28 (85.7%)3/7 (42.9%)2/7 (18.2%)
Nalidixic acid45/121 (37.2%)33/36 (91.7%)0/7 (0.0%)5/28 (17.9%)0/7 (0.0%)0/11 (0.0%)
Cetriaxone83/117 (70.9%)31/35 (88.6%)5/7 (71.4%)24/25 (96.0%)7/7 (100.0%)11/11 (100.0%)
Cephalexin74/119 (62.2%)29/36 (80.6%)6/7 (85.7%)26/28 (92.9%)5/7 (71.4%)11/711 (100.0%)
  1. an/N in each cell report the (number of bacterial isolates susceptible to the specified antibiotic)/(number of urine samples with bacterial species isolated)